Financial research concept

Dialysis Normalized Non-Acquired Treatment Growth

measures year-over-year treatment-volume growth after excluding acquisitions and similar transactions and normalizing for the number and mix of treatment days.

By Lee BaileyPublished Sep 25, 2026

Research context

See what supports this page, how current it is, and where comparable or historical context is available.

Research date: Sep 25, 2026Use the dated article and cited sources for the definition, examples, and stated limitations.
Operating-model context: 17 connected conceptsPart of the reviewed Dialysis Provider Economics; issuer definitions remain distinct where disclosed.
Company examples: 1 reviewed companyRelationships reflect supported examples, not a normalized cross-company KPI ranking.

The metric shows slight underlying volume contraction
Calendar normalization matters when treatment days differ
This is an issuer-defined organic-volume measure
Part of the Dialysis Provider Economics
See It in Company Research
Continue Research

Dialysis Normalized Non-Acquired Treatment Growth measures year-over-year treatment-volume growth excluding acquired activity and normalizing for treatment-day mix under DaVita's methodology.

DaVita reported negative 0.8% normalized non-acquired treatment growth in 2025.

The metric shows slight underlying volume contraction

A negative 0.8% result means the normalized pre-existing treatment base declined modestly year over year.

That is different from simply comparing reported annual treatment totals because acquisitions and calendar mix are removed.

Calendar normalization matters when treatment days differ

DaVita separately reported 313.0 treatment days and 91,802 average treatments per day.

Use Dialysis Treatment Days and Dialysis Average Treatments per Day to keep the operating calendar visible.

This is an issuer-defined organic-volume measure

It is not a same-store metric and should not be compared mechanically with organic growth definitions used by other healthcare companies.

The negative 0.8% figure describes DaVita's own normalized methodology.

Primary source: DaVita 2025 Form 10-K.

Part of the Dialysis Provider Economics

Connect treatment activity, reimbursement per treatment, patient-care cost, modality and payor mix, collections, network footprint, market share, and segment profitability across a dialysis provider.

Browse the full operating model in Company Analysis →

Where this concept fits

Treatment volume, patient base, and network footprintCurrent relationship
Treatment volume, average daily treatments, treatment days, patient count, outpatient centers, hospital service contracts, market share, and normalized non-acquired growth show the operating scale and underlying demand base. Center count and patient count are point-in-time measures, while treatments are period activity.
Dialysis Average Treatments per Day Dialysis Hospital Service Contract CountDialysis Normalized Non-Acquired Treatment GrowthCurrent conceptDialysis Outpatient Center Count Dialysis Patient Count Dialysis Treatment Days Dialysis Treatment Volume Dialysis U.S. Market Share
Reimbursement, payor mix, and care setting
Average patient service revenue per treatment shows blended reimbursement, government and commercial revenue mix show payor economics, and outpatient, home-based, and hospital inpatient revenue mix show where care is delivered. Revenue shares are not interchangeable with patient or treatment shares.
Dialysis Average Patient Service Revenue per Treatment Dialysis Commercial Revenue Mix Dialysis Government Revenue Mix Dialysis Home-Based Revenue Mix Dialysis Hospital Inpatient Revenue Mix Dialysis Outpatient Revenue Mix
Cost, collections, and segment profitability
Patient care cost per treatment frames direct operating cost, days sales outstanding shows collections efficiency, and segment operating income shows the resulting GAAP segment contribution after the issuer's reported expense structure.
Dialysis Days Sales Outstanding Dialysis Patient Care Cost per Treatment Dialysis Segment Operating Income

See It in Company Research

These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.

DVAOpen operating-model research →17 of 17 reviewed concepts in Dialysis Provider EconomicsTreatment volume, patient base, and network footprint8 of 8 bridge concepts supportedContinue through this bridge:Dialysis Average Treatments per Day Dialysis Hospital Service Contract Count Dialysis Outpatient Center Count Dialysis Patient Count Dialysis Treatment Days Dialysis Treatment Volume Dialysis U.S. Market Share

Continue Research

Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.

Continue Research

Compare public companies

Compare DaVita's negative 0.8% underlying volume measure with its calendar and reported treatment activity.

Continue research

Explore more topics in the Financial Research Encyclopedia.